Cargando…

The challenges of identifying and studying type 1 diabetes in adults

Diagnosing type 1 diabetes in adults is difficult since type 2 diabetes is the predominant diabetes type, particularly with an older age of onset (approximately >30 years). Misclassification of type 1 diabetes in adults is therefore common and will impact both individual patient management and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Nicholas J., Jones, Angus G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628058/
https://www.ncbi.nlm.nih.gov/pubmed/37728732
http://dx.doi.org/10.1007/s00125-023-06004-4
_version_ 1785131671671013376
author Thomas, Nicholas J.
Jones, Angus G.
author_facet Thomas, Nicholas J.
Jones, Angus G.
author_sort Thomas, Nicholas J.
collection PubMed
description Diagnosing type 1 diabetes in adults is difficult since type 2 diabetes is the predominant diabetes type, particularly with an older age of onset (approximately >30 years). Misclassification of type 1 diabetes in adults is therefore common and will impact both individual patient management and the reported features of clinically classified cohorts. In this article, we discuss the challenges associated with correctly identifying adult-onset type 1 diabetes and the implications of these challenges for clinical practice and research. We discuss how many of the reported differences in the characteristics of autoimmune/type 1 diabetes with increasing age of diagnosis are likely explained by the inadvertent study of mixed populations with and without autoimmune aetiology diabetes. We show that when type 1 diabetes is defined by high-specificity methods, clinical presentation, islet-autoantibody positivity, genetic predisposition and progression of C-peptide loss remain broadly similar and severe at all ages and are unaffected by onset age within adults. Recent clinical guidance recommends routine islet-autoantibody testing when type 1 diabetes is clinically suspected or in the context of rapid progression to insulin therapy after a diagnosis of type 2 diabetes. In this moderate or high prior-probability setting, a positive islet-autoantibody test will usually confirm autoimmune aetiology (type 1 diabetes). We argue that islet-autoantibody testing of those with apparent type 2 diabetes should not be routinely undertaken as, in this low prior-prevalence setting, the positive predictive value of a single-positive islet antibody for autoimmune aetiology diabetes will be modest. When studying diabetes, extremely high-specificity approaches are needed to identify autoimmune diabetes in adults, with the optimal approach depending on the research question. We believe that until these recommendations are widely adopted by researchers, the true phenotype of late-onset type 1 diabetes will remain largely misunderstood. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material, including a slideset of the figures for download, available at 10.1007/s00125-023-06004-4.
format Online
Article
Text
id pubmed-10628058
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-106280582023-11-08 The challenges of identifying and studying type 1 diabetes in adults Thomas, Nicholas J. Jones, Angus G. Diabetologia Review Diagnosing type 1 diabetes in adults is difficult since type 2 diabetes is the predominant diabetes type, particularly with an older age of onset (approximately >30 years). Misclassification of type 1 diabetes in adults is therefore common and will impact both individual patient management and the reported features of clinically classified cohorts. In this article, we discuss the challenges associated with correctly identifying adult-onset type 1 diabetes and the implications of these challenges for clinical practice and research. We discuss how many of the reported differences in the characteristics of autoimmune/type 1 diabetes with increasing age of diagnosis are likely explained by the inadvertent study of mixed populations with and without autoimmune aetiology diabetes. We show that when type 1 diabetes is defined by high-specificity methods, clinical presentation, islet-autoantibody positivity, genetic predisposition and progression of C-peptide loss remain broadly similar and severe at all ages and are unaffected by onset age within adults. Recent clinical guidance recommends routine islet-autoantibody testing when type 1 diabetes is clinically suspected or in the context of rapid progression to insulin therapy after a diagnosis of type 2 diabetes. In this moderate or high prior-probability setting, a positive islet-autoantibody test will usually confirm autoimmune aetiology (type 1 diabetes). We argue that islet-autoantibody testing of those with apparent type 2 diabetes should not be routinely undertaken as, in this low prior-prevalence setting, the positive predictive value of a single-positive islet antibody for autoimmune aetiology diabetes will be modest. When studying diabetes, extremely high-specificity approaches are needed to identify autoimmune diabetes in adults, with the optimal approach depending on the research question. We believe that until these recommendations are widely adopted by researchers, the true phenotype of late-onset type 1 diabetes will remain largely misunderstood. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material, including a slideset of the figures for download, available at 10.1007/s00125-023-06004-4. Springer Berlin Heidelberg 2023-09-20 2023 /pmc/articles/PMC10628058/ /pubmed/37728732 http://dx.doi.org/10.1007/s00125-023-06004-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Thomas, Nicholas J.
Jones, Angus G.
The challenges of identifying and studying type 1 diabetes in adults
title The challenges of identifying and studying type 1 diabetes in adults
title_full The challenges of identifying and studying type 1 diabetes in adults
title_fullStr The challenges of identifying and studying type 1 diabetes in adults
title_full_unstemmed The challenges of identifying and studying type 1 diabetes in adults
title_short The challenges of identifying and studying type 1 diabetes in adults
title_sort challenges of identifying and studying type 1 diabetes in adults
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628058/
https://www.ncbi.nlm.nih.gov/pubmed/37728732
http://dx.doi.org/10.1007/s00125-023-06004-4
work_keys_str_mv AT thomasnicholasj thechallengesofidentifyingandstudyingtype1diabetesinadults
AT jonesangusg thechallengesofidentifyingandstudyingtype1diabetesinadults
AT thomasnicholasj challengesofidentifyingandstudyingtype1diabetesinadults
AT jonesangusg challengesofidentifyingandstudyingtype1diabetesinadults